Background
Post-obstructive pneumonia occurs in the presence of airway obstruction, usually caused by lung cancer [1] . However, there are cases of bronchial obstruction due to benign origin such as foreign bodies and benign endobronchial tumors, which are often misdiagnosed. We report a case of endobronchial hamartoma that caused post-obstructive pneumonia.
Case Report
A 66-year-old man was referred to our hospital due to high fever with an abnormal shadow in the upper field of the right lung on chest radiograph. Based on the diagnosis of pneumonia, he was treated with antibiotics for 3 days prior to the visit to our hospital. On examination, he was afebrile and showed no abnormal physical findings, including breath sounds. Laboratory tests showed an elevated level of C-reactive protein with no abnormality in serum tumor makers or other data. Chest radiography showed a localized consolidation in the right upper lung ( Figure 1A ) and computed tomography (CT) showed a linear atelectasis. A follow-up CT scan 6 weeks later revealed a and fat tissue in the deeper layer, and was finally diagnosed as endobronchial chondroid hamartoma ( Figure 4A and 4B). Several peripheral bronchi were filled with mucus and infiltrated with inflammatory cells, suggesting recurrent bronchitis or localized pneumonia. There was no evidence of recurrence of the tumor or post-obstructive pneumonia during the 6-month post-operative period.
Discussion
Post-obstructive pneumonia is difficult to treat with antibiotics alone because of poor drainage, and can lead to recurrent hospitalization, increased medical costs, and poor outcomes [1] . Actual incidence and cause of obstructive pneumonia has not been well elucidated; however, lung cancer has been considered as the most common cause of post-obstructive pneumonia, occurring in approximately 20% of the patients with proximal airway obstruction [1] . Benign diseases (e.g., foreign bodies, benign tumors, granulomatous diseases such as tuberculosis, or broncholithiasis) can obstruct the airways and induce post-obstructive pneumonia [1] [2] [3] [4] [5] . Jhun et al. reported that 31% of the patients with benign endobronchial tumors exhibited obstructive pneumonia on chest CT scan [3] .
Hamartomas occurs anywhere in the lung [6] , but are rarely identified as an endobronchial lesion; in a series of 215 pulmonary hamartomas, only 1.4% were located endobronchially [6] . Although most patients with parenchymal hamartoma are asymptomatic [6] , it is important to consider the possibility of endobronchial hamartoma as a cause of post-obstructive pneumonia for 2 reasons. Firstly, hamartoma is a relatively common pathology among endobronchial benign tumors. In a review of 185 benign tracheobronchial tumors, 45 hamartomas and 15 hamartochondromas were reported [7] . Another case series from Korea reported that hamartomas accounts for 44% (24/55 cases) of benign endobronchial tumors, and two-thirds of these were chondroid hamartomas [3] . Secondly, many endobronchial hamartomas are accompanied by recurrent pulmonary infection. In the largest case series, Cosio et al. [8] reported 43 cases of endobronchial hamartoma, most diagnosed during examination of recurrent respiratory infection (37%) or bloody sputum (32%) [8] . In a Korean study that reviewed 24 cases of endobronchial hamartoma, 10 cases (42%) showed obstructive pneumonia [3] .
Recent reports demonstrate successful endobronchial resection of endobronchial hamartomas using laser or snare, without recurrence or regrowth of the tumor [9] [10] [11] . Several reports demonstrated successful endobronchial resection of endobronchial hamartomas using laser or electrocautery snare without recurrence or regrowth of the tumor [9] [10] [11] . Recently, other methods such as cryotherapy [12] , argon plasma coagulation (APC) [13] , or combination of different methods [13] have been reported.
Because hamartomas rarely recur or transform into malignancy [6] [7] [8] [9] [10] [11] 14] , a minimally invasive procedure should be selected. In the present case, however, it was impossible to remove it endobronchially because we could not identify its stoke, which separates normal tissue from a tumor. Surgical approach is still an effective therapy for an intra-bronchial tumor that is difficult diagnose or remove by bronchoscopic approach [15, 16] , 
Conclusions
Clinicians should consider the possibility of an intra-bronchial benign tumor such as hamartoma in the differential diagnosis
